QUANTUM GENOMICS AS

Quantum Genomics is a biopharmaceutical company specializing in the development of a new drug class for unmet medical needs in cardiovascular disease, including high blood pressure and heart failure... Quantum Genomics is the only biopharmaceutical company specializing in the development of a new drug class based on the central action mechanism of Aminopeptidase A inhibition.

Also known as: QuantumGenomics

VAT numbers: FR 90 487 996 647

Primary location: Paris France